Nyxoah S.A.(NYXH)Earnings, Financials & Key Ratios
NYXH•NASDAQ
Price updated Jun 11, 2026
AboutNyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.Show more
- Revenue$10M+121.6%
- EBITDA-$78M-35.2%
- Net Income-$90M-52.1%
- EPS (Diluted)-2.37-30.9%
- Gross Margin63.13%-3.9%
- EBITDA Margin-783.01%+39.0%
- Operating Margin-827.76%+36.4%
- Net Margin-899.05%+31.4%
- ROE-110.97%-97.9%
- ROIC-76.37%-65.2%
- Debt/Equity0.86+328.2%
- Interest Coverage-51.68-67.2%
NYXH Key Insights
Nyxoah S.A. (NYXH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 170.6%
- ✓Trading at only 1.0x book value
✗Weaknesses
- ✗Profits declining 49.1% over 5 years
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Shares diluted 16.4% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NYXH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NYXH Price & Volume
Nyxoah S.A. (NYXH) stock price & volume — 10-year historical chart
Loading chart...
NYXH Growth Metrics
Nyxoah S.A. (NYXH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years170.65%
3 Years48.11%
TTM273.92%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-23.53%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-7.54%
Return on Capital
10 Years-50.74%
5 Years-41.19%
3 Years-55.18%
Last Year-80.38%
NYXH Recent Earnings
Nyxoah S.A. (NYXH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 12, 2026EPS
$0.43
Est $0.54
+20.4%
Revenue
$7M
Est $7M
+4.4%
Q2 2026
Mar 19, 2026EPS
$0.68
Est $0.65
-4.6%
Revenue
$7M
Est $5M
+23.1%
Q4 2025
Nov 13, 2025EPS
$0.74
Est $0.61
-21.3%
Revenue
$2M
Est $6M
-59.4%
Q3 2025
Aug 18, 2025EPS
$0.63
Est $0.62
-1.6%
Revenue
$2M
Est $3M
-40.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.43vs $0.54+20.4% | $7Mvs $7M+4.4% |
| Q2 2026 | Mar 19, 2026 | $0.68vs $0.65-4.6% | $7Mvs $5M+23.1% |
| Q4 2025 | Nov 13, 2025 | $0.74vs $0.61-21.3% | $2Mvs $6M-59.4% |
| Q3 2025 | Aug 18, 2025 | $0.63vs $0.62-1.6% | $2Mvs $3M-40.7% |
Based on last 12 quarters of dataView full earnings history →
NYXH Peer Comparison
Nyxoah S.A. (NYXH) competitors in Patient monitoring and respiratory care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 INSP | 1.22B | 42.44 | 8.68 | 13.6% | 14.33% | 17.98% | 0.04 | |
 LIVN | 4.39B | 79.94 | -17.96 | 10.74% | 7.47% | 9.13% | 0.39 | |
 AVAV | 9.17B | 183.69 | 118.51 | 14.5% | -13.93% | -6.41% | 0.07 | |
 NVCR | 2.02B | 17.71 | -14.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ELMD | 311.41M | 37.61 | 43.73 | 16.97% | 14.08% | 22.14% | 0.00 | |
 RMTI | 24.57M | 0.62 | -4.15 | -31.76% | -9.25% | -45.88% | 0.34 | |
 MDT | 103.13B | 80.33 | 22.25 | 3.62% | 13% | 9.49% | 0.59 | |
 ABT | 155.89B | 89.65 | 11.73 | 4.59% | 31.88% | 27.26% | 0.32 |
Compare NYXH vs Peers
Nyxoah S.A. (NYXH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NYXH Income Statement
Nyxoah S.A. (NYXH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 69K | 852K | 3.08M | 4.35M | 4.52M | 10.02M | 16.32M |
Revenue Growth % | - | - | - | - | 1134.78% | 261.97% | 40.99% | 3.98% | 121.63% | 273.92% |
Cost of Goods Sold | 2.11M | 2.52M | 486.04K | 30K | 303K | 1.15M | 1.66M | 1.55M | 3.69M | 8.43M |
COGS % of Revenue | - | - | - | 43.48% | 35.56% | 37.29% | 38.09% | 34.33% | 36.87% | - |
Gross Profit | -2.11M▲ 0% | -2.52M▼ 19.6% | -486.04K▲ 80.7% | 39K▲ 108.0% | 549K▲ 1307.7% | 1.93M▲ 252.3% | 2.69M▲ 39.2% | 2.97M▲ 10.3% | 6.33M▲ 113.1% | 7.89M▲ 0% |
Gross Margin % | - | - | - | 56.52% | 64.44% | 62.71% | 61.91% | 65.67% | 63.13% | 48.34% |
Gross Profit Growth % | - | -19.57% | 80.74% | 108.02% | 1307.69% | 252.28% | 39.19% | 10.29% | 113.07% | - |
Operating Expenses | 10.14M | 8.45M | 8.03M | 11.26M | 26.79M | 34.43M | 47.79M | 61.78M | 89.27M | 93.92M |
OpEx % of Revenue | - | - | - | 16323.19% | 3144.48% | 1116.5% | 1099.22% | 1366.47% | 890.9% | - |
Selling, General & Admin | 4.12M | 4.35M | 6.39M | 11.35M | 11.11M | 18.86M | 20.64M | 28.46M | 46.44M | 51.66M |
SG&A % of Revenue | - | - | - | 16442.03% | 1304.34% | 611.38% | 474.82% | 629.53% | 463.44% | - |
Research & Development | 2M | 1.72M | 1.64M | 2.91M | 5.95M | 15.86M | 27.66M | 34.33M | 42.82M | 42.56M |
R&D % of Revenue | - | - | - | 4217.39% | 698.59% | 514.3% | 636.06% | 759.23% | 427.39% | - |
Other Operating Expenses | 4.58M | 2.81M | 0 | -2.99M | 9.73M | -283K | -507K | -1.01M | 7K | -296K |
Operating Income | -10.14M▲ 0% | -8.45M▲ 16.7% | -8.52M▼ 0.8% | -11.22M▼ 31.8% | -26.24M▼ 133.8% | -32.5M▼ 23.8% | -45.1M▼ 38.8% | -58.81M▼ 30.4% | -82.94M▼ 41.0% | -86.04M▲ 0% |
Operating Margin % | - | - | - | -16266.67% | -3080.05% | -1053.79% | -1037.3% | -1300.8% | -827.76% | -527.24% |
Operating Income Growth % | - | 16.69% | -0.81% | -31.76% | -133.8% | -23.84% | -38.78% | -30.39% | -41.04% | - |
EBITDA | -10.06M | -8.36M | -8.03M | -10.6M | -24.58M | -30.57M | -42.74M | -58.05M | -78.46M | -80.76M |
EBITDA Margin % | - | - | - | -15368.12% | -2884.98% | -991.15% | -983.03% | -1283.9% | -783.01% | -494.92% |
EBITDA Growth % | - | 16.92% | 3.86% | -32.01% | -131.8% | -24.36% | -39.83% | -35.8% | -35.17% | -24.01% |
D&A (Non-Cash Add-back) | 87K | 95K | 486.04K | 620K | 1.66M | 1.93M | 2.36M | 764K | 4.48M | 5.27M |
EBIT | -10.3M | -9.01M | -8.71M | -11.22M | -24.25M | -29.82M | -44.44M | -58.81M | -87.39M | -89.55M |
Net Interest Income | -35K | -28K | -692.58K | -195K | -385K | 135K | 1.37M | 599K | 143K | -1.65M |
Interest Income | 2K | 1K | 8.98K | 3K | 1K | 372K | 2.57M | 2.5M | 1.83M | 1.08M |
Interest Expense | 37K | 29K | 701.56K | 198K | 386K | 237K | 1.21M | 1.9M | 1.69M | 2.74M |
Other Income/Expense | -191K | -588K | -892.39K | -928K | 1.6M | 2.44M | 445K | 2.38M | -6.13M | 1.25M |
Pretax Income | -10.33M▲ 0% | -9.04M▲ 12.5% | -9.41M▼ 4.1% | -12.15M▼ 29.1% | -24.64M▼ 102.8% | -30.06M▼ 22.0% | -44.66M▼ 48.6% | -56.43M▼ 26.4% | -89.08M▼ 57.8% | -84.79M▲ 0% |
Pretax Margin % | - | - | - | -17611.59% | -2891.9% | -974.58% | -1027.07% | -1248.22% | -888.98% | -519.6% |
Income Tax | 37K | 41K | 78.57K | 93K | 2.98M | 1.17M | -1.45M | 2.8M | 1.01M | 1.33M |
Effective Tax Rate % | -0.36% | -0.45% | -0.83% | -0.77% | -12.09% | -3.89% | 3.24% | -4.97% | -1.13% | -1.57% |
Net Income | -10.37M▲ 0% | -9.08M▲ 12.5% | -9.49M▼ 4.5% | -12.24M▼ 29.0% | -27.62M▼ 125.6% | -31.23M▼ 13.1% | -43.21M▼ 38.4% | -59.24M▼ 37.1% | -90.08M▼ 52.1% | -86.12M▲ 0% |
Net Margin % | - | - | - | -17746.38% | -3241.67% | -1012.48% | -993.84% | -1310.24% | -899.05% | -527.77% |
Net Income Growth % | - | 12.46% | -4.52% | -29.04% | -125.55% | -13.06% | -38.39% | -37.08% | -52.08% | -23.53% |
Net Income (Continuing) | -10.37M | -9.08M | -9.49M | -12.24M | -27.62M | -31.23M | -43.21M | -59.24M | -90.08M | -86.12M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.50▲ 0% | -0.43▲ 14.0% | -0.34▲ 20.9% | -0.68▼ 100.0% | -1.16▼ 70.6% | -1.21▼ 4.3% | -1.55▼ 28.1% | -1.81▼ 16.8% | -2.37▼ 30.9% | -1.99▲ 0% |
EPS Growth % | - | 14% | 20.93% | -100% | -70.59% | -4.31% | -28.1% | -16.77% | -30.94% | -7.54% |
EPS (Basic) | -0.50 | -0.43 | -0.34 | -0.68 | -1.16 | -1.21 | -1.55 | -1.81 | -2.37 | - |
Diluted Shares Outstanding | 20.89M | 20.89M | 21.42M | 18.1M | 23.79M | 25.82M | 27.97M | 32.74M | 38.11M | 43.21M |
Basic Shares Outstanding | 20.89M | 20.89M | 21.42M | 18.1M | 23.79M | 25.82M | 27.97M | 32.74M | 38.11M | 43.21M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NYXH Balance Sheet
Nyxoah S.A. (NYXH) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 10.68M | 17.54M | 8.95M | 115.15M | 140.06M | 100.26M | 68.35M | 98.08M | 61.19M | 40.72M |
Cash & Short-Term Investments | 10.11M | 16.8M | 6.57M | 112.93M | 135.51M | 94.86M | 57.75M | 85.56M | 47.98M | 26.03M |
Cash Only | 10.11M | 16.8M | 6.57M | 112.93M | 135.51M | 17.89M | 21.61M | 34.19M | 29.99M | 12.98M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 76.97M | 36.14M | 51.37M | 17.99M | 13.05M |
Accounts Receivable | 575K | 732K | 2.37M | 2.01M | 2.51M | 2.23M | 5.63M | 3.38M | 7.72M | 9.25M |
Days Sales Outstanding | - | - | - | 10.64K | 1.08K | 264.05 | 472.37 | 273.04 | 281.26 | 141.01 |
Inventory | -575K | -732K | 0 | 67.3K | 346K | 882K | 3.31M | 4.72M | 4.66M | 4.36M |
Days Inventory Outstanding | - | - | - | 818.76 | 416.8 | 279.94 | 730.66 | 1.11K | 460.28 | 221.18 |
Other Current Assets | 0 | 0 | 0 | 0 | 3.98M | 828K | 1.66M | 4.43M | 827.69K | 567.15K |
Total Non-Current Assets | 461K | 440K | 8.11M | 24.44M | 30.77M | 45.81M | 55.81M | 60.32M | 57.24M | 57.25M |
Property, Plant & Equipment | 369K | 343K | 1.56M | 4.89M | 5.24M | 5.62M | 7.98M | 8.25M | 5.34M | 6.01M |
Fixed Asset Turnover | - | - | - | 0.01x | 0.16x | 0.55x | 0.55x | 0.55x | 1.88x | 2.53x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 6.44M | 19.4M | 25.32M | 39.97M | 46.61M | 50.38M | 50.09M | 49.42M |
Long-Term Investments | 70K | 68K | 87.55K | 111.34K | 164K | 173K | 0 | 0 | 1.72M | 1.8M |
Other Non-Current Assets | 70K | 68K | 0 | 0 | 0 | 0 | 1.17M | 1.69M | 0 | 0 |
Total Assets | 11.14M▲ 0% | 17.98M▲ 61.3% | 17.06M▼ 5.1% | 139.58M▲ 718.4% | 170.83M▲ 22.4% | 146.07M▼ 14.5% | 124.16M▼ 15.0% | 158.41M▲ 27.6% | 118.43M▼ 25.2% | 97.97M▲ 0% |
Asset Turnover | - | - | - | 0.00x | 0.00x | 0.02x | 0.04x | 0.03x | 0.08x | 0.15x |
Asset Growth % | - | 61.32% | -5.13% | 718.36% | 22.39% | -14.49% | -15% | 27.59% | -25.24% | -108.99% |
Total Current Liabilities | 1.75M | 2M | 4.91M | 7.83M | 11.57M | 14.91M | 14.44M | 21.53M | 48.94M | 41.21M |
Accounts Payable | 389K | 606K | 1.55M | 1.46M | 2.39M | 1.87M | 4.1M | 3.75M | 13.72M | 12.69M |
Days Payables Outstanding | 67.29 | 87.67 | 1.17K | 17.71K | 2.88K | 594.47 | 904.12 | 881.69 | 1.36K | 344.78 |
Short-Term Debt | 395K | 289K | 805.95K | 1.33M | 554K | 389K | 364K | 248K | 23.76M | 17.26M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117K | 893.66K | 2.48M |
Other Current Liabilities | 257K | 316K | 1.85M | 4.12M | 1.15M | 621K | 1.08M | 2.36M | 6.63M | 2.64M |
Current Ratio | 6.11x | 8.77x | 1.82x | 14.70x | 12.10x | 6.72x | 4.73x | 4.56x | 1.25x | 0.99x |
Quick Ratio | 6.44x | 9.14x | 1.82x | 14.69x | 12.07x | 6.66x | 4.50x | 4.34x | 1.16x | 0.88x |
Cash Conversion Cycle | - | - | - | -6.26K | -1.39K | -50.49 | 298.9 | 500.46 | -614.31 | 17.41 |
Total Non-Current Liabilities | 4.87M | 5.53M | 9.49M | 12.83M | 10.64M | 10.83M | 11.69M | 23.62M | 20.38M | 20.75M |
Long-Term Debt | 4.87M | 5.53M | 8.02M | 9.31M | 7.8M | 8.19M | 8.37M | 18.73M | 17.66M | 17.5M |
Capital Lease Obligations | 0 | 0 | 825.04K | 3.48M | 2.74M | 2.59M | 3.12M | 2.56M | 636.76K | 5.63M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 5K | 0 | 9K | 0 | 0 | 68.13K |
Other Non-Current Liabilities | 0 | 0 | 647.68K | 45.27K | 92K | 59K | 194K | 2.34M | 1.4M | 1.04M |
Total Liabilities | 6.62M | 7.53M | 14.41M | 20.67M | 22.21M | 25.75M | 26.14M | 45.15M | 69.34M | 61.96M |
Total Debt | 5.26M | 5.82M | 9.65M | 14.12M | 11.68M | 11.88M | 12.7M | 22.65M | 42.06M | 36.22M |
Net Debt | -4.84M | -10.99M | 3.08M | -98.81M | -123.83M | -6.01M | -8.91M | -11.53M | 12.07M | 23.23M |
Debt / Equity | 1.16x | 0.56x | 3.64x | 0.12x | 0.08x | 0.10x | 0.13x | 0.20x | 0.86x | 1.01x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.45x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.29x |
Interest Coverage | -278.30x | -310.66x | -12.41x | -56.69x | -62.83x | -125.82x | -36.82x | -30.90x | -51.68x | -32.73x |
Total Equity | 4.53M▲ 0% | 10.45M▲ 130.9% | 2.65M▼ 74.6% | 118.92M▲ 4387.1% | 148.62M▲ 25.0% | 120.32M▼ 19.0% | 98.02M▼ 18.5% | 113.25M▲ 15.5% | 49.11M▼ 56.6% | 36.01M▲ 0% |
Equity Growth % | - | 130.93% | -74.65% | 4387.05% | 24.98% | -19.04% | -18.54% | 15.54% | -56.64% | -208.12% |
Book Value per Share | 0.22 | 0.50 | 0.12 | 6.57 | 6.25 | 4.66 | 3.50 | 3.46 | 1.29 | 0.83 |
Total Shareholders' Equity | 4.53M | 10.45M | 2.65M | 118.92M | 148.62M | 120.32M | 98.02M | 113.25M | 49.11M | 36.01M |
Common Stock | 2M | 2.48M | 2.78M | 4.64M | 4.43M | 4.44M | 4.93M | 6.43M | 6.5M | 6.54M |
Retained Earnings | -30.73M | -39.81M | -54.35M | -73.83M | -87.17M | -118.21M | -160.83M | -217.74M | -305.91M | -322.95M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 63K | 39K | 703.81K | 3.42M | 202K | 176K | 137K | 10.21M | 13.51M | 13.9M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NYXH Cash Flow Statement
Nyxoah S.A. (NYXH) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -8.29M | -8.14M | -5.93M | -6.86M | -25.34M | -28.76M | -44.78M | -49.23M | -67.5M | -71.96M |
Operating CF Margin % | - | - | - | -9947.83% | -2973.71% | -932.43% | -1029.85% | -1088.83% | -673.61% | - |
Operating CF Growth % | - | 1.79% | 27.12% | -15.71% | -269.11% | -13.5% | -55.72% | -9.93% | -37.11% | -124.63% |
Net Income | -10.33M | -9.04M | -8.38M | -12.15M | -24.64M | -30.06M | -44.66M | -56.43M | -90.05M | -86.12M |
Depreciation & Amortization | 87K | 95K | 433K | 620K | 1.66M | 1.93M | 2.36M | 2.72M | 4.48M | 5.43M |
Stock-Based Compensation | 24K | 28K | 346K | 2.55M | 1.27M | 2.7M | 2.61M | 3.97M | 0 | 887K |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 2.39M | 575K | 716K | 700K | -2.48M | -3.42M | -1.6M | -2.44M | 12.7M | 6.97M |
Working Capital Changes | -454K | 201K | 957K | 1.42M | -1.14M | 86K | -3.49M | 2.96M | 5.37M | -1.55M |
Change in Receivables | -161K | -155K | -1.39M | 365K | -2.52M | 7K | -1.54M | -751K | -2.14M | -5.03M |
Change in Inventory | 0 | 0 | 0 | -55K | -291K | -536K | -2.43M | -1.4M | 55.98K | 632.65K |
Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.45M | 2.84M |
Cash from Investing | -91K | -75K | -5.79M | -10.69M | -11.82M | -89.95M | 32.01M | -16.32M | 26.17M | 24.61M |
Capital Expenditures | -91K | -77K | -51K | -562K | -1.47M | -886K | -2.5M | -1.17M | -3.77M | -2.69M |
CapEx % of Revenue | - | - | - | 814.49% | 172.42% | 28.73% | 57.5% | 25.77% | 37.6% | 16.47% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 453.72K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 2K | -5.73M | -10.12M | -10.35M | -15.35M | -6.15M | -2.64M | 0 | 28.05M |
Cash from Financing | 1.11M | 15M | 700K | 104.03M | 76.47M | -983K | 16.86M | 77.44M | 38.79M | 38.51M |
Debt Issued (Net) | 1.11M | 0 | 733K | 593K | -863K | -1.07M | -1.24M | 8.47M | 21.19M | 21.45M |
Equity Issued (Net) | 0 | 15M | 0 | 103.58M | 77.73M | 255K | 18.34M | 69.72M | 20.86M | 20.76M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 0 | 0 | -33K | -151K | -393K | -167K | -243K | -758K | -3.26M | -3.7M |
Net Change in Cash | -7.34M▲ 0% | 6.7M▲ 191.3% | -10.95M▼ 263.4% | 86.44M▲ 889.5% | 43.21M▼ 50.0% | -117.62M▼ 372.2% | 3.72M▲ 103.2% | 12.58M▲ 237.9% | -130.69K▼ 101.0% | -10.02M▲ 0% |
Free Cash Flow | -8.38M▲ 0% | -8.22M▲ 1.9% | -11.72M▼ 42.6% | -17.54M▼ 49.7% | -37.15M▼ 111.8% | -45.1M▼ 21.4% | -55.74M▼ 23.6% | -55.3M▲ 0.8% | -68.3M▼ 23.5% | -73.28M▲ 0% |
FCF Margin % | - | - | - | -25426.09% | -4360.68% | -1462.55% | -1281.97% | -1223.14% | -681.64% | -449.1% |
FCF Growth % | - | 1.93% | -42.61% | -49.73% | -111.77% | -21.4% | -23.58% | 0.79% | -23.51% | -23.5% |
FCF per Share | -0.40 | -0.39 | -0.55 | -0.97 | -1.56 | -1.75 | -1.99 | -1.69 | -1.79 | -1.70 |
FCF Conversion (FCF/Net Income) | 0.80x | 0.90x | 0.63x | 0.56x | 0.92x | 0.92x | 1.04x | 0.83x | 0.75x | 0.85x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 306K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NYXH Key Ratios
Nyxoah S.A. (NYXH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -121.21% | -144.83% | -20.15% | -20.65% | -23.22% | -39.58% | -56.07% | -110.97% | -164.44% |
| Return on Invested Capital (ROIC) | - | -246% | -65.17% | -87.69% | -35.04% | -33.26% | -46.22% | -76.37% | -103.05% |
| Gross Margin | - | - | 56.52% | 64.44% | 62.71% | 61.91% | 65.67% | 63.13% | 48.34% |
| Net Margin | - | - | -17746.38% | -3241.67% | -1012.48% | -993.84% | -1310.24% | -899.05% | -527.77% |
| Debt / Equity | 0.56x | 3.64x | 0.12x | 0.08x | 0.10x | 0.13x | 0.20x | 0.86x | 1.01x |
| Interest Coverage | -310.66x | -12.41x | -56.69x | -62.83x | -125.82x | -36.82x | -30.90x | -51.68x | -32.73x |
| FCF Conversion | 0.90x | 0.63x | 0.56x | 0.92x | 0.92x | 1.04x | 0.83x | 0.75x | 0.85x |
| Revenue Growth | - | - | - | 1134.78% | 261.97% | 40.99% | 3.98% | 121.63% | 273.92% |
Related:NYXH Dividend History·NYXH Revenue History·NYXH Price History·NYXH P/E History·NYXH Financial Ratios·NYXH Institutional Holders
NYXH Frequently Asked Questions
Nyxoah S.A. (NYXH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Nyxoah S.A. (NYXH) reported $16.3M in revenue for fiscal year 2025.
Nyxoah S.A. (NYXH) grew revenue by 121.6% over the past year. This is strong growth.
Nyxoah S.A. (NYXH) reported a net loss of $86.1M for fiscal year 2025.
Dividend & Returns
Nyxoah S.A. (NYXH) has a return on equity (ROE) of -111.0%. Negative ROE indicates the company is unprofitable.
Nyxoah S.A. (NYXH) had negative free cash flow of $73.3M in fiscal year 2025, likely due to heavy capital investments.